FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for AMYVID (florbetapir F-18) from Eli Lilly and Company, an imaging agent used to assess beta-amyloid plaques in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

SUPPL AP for AMYVID (FLORBETAPIR F 18)